Socioeconomic and Clinical Factors Influence the Interval Between Positive Prostate Biopsy and Radical Prostatectomy

被引:18
|
作者
Pitman, Max [1 ]
Korets, Ruslan [1 ]
Kates, Max [1 ]
Hruby, Gregory W. [1 ]
McKiernan, James M. [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Urol, New York, NY 10032 USA
关键词
RACIAL-DIFFERENCES; CANCER-PATIENTS; EQUAL-ACCESS; LOW-INCOME; OUTCOMES; MEN; RISK; POPULATION; MARRIAGE; SURVIVAL;
D O I
10.1016/j.urology.2012.01.008
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To examine socioeconomic and clinical factors that may predict a longer interval between prostate biopsy and radical prostatectomy (RP). METHODS The Columbia University Urologic Oncology Database was queried for patients who underwent RP from 1990-2010. Time to surgery (TTS) was defined as the period between the most recent positive prostate biopsy and date of surgery. Clinical factors examined included: age, D'Amico risk group, year of surgery, body mass index, and comorbidities. Socioeconomic factors included race/ethnicity, relationship status, income, and distance to treatment center. The relationship between clinical/socioeconomic factors and TTS was evaluated using univariate and multivariate regression models. RESULTS Two-thousand five-hundred seventy-three patients were included in the analysis. Median TTS was 48 days (IQR 35-70, range 43-1103), and 71% of patients underwent RP within 60 days after the most recent positive biopsy. On multivariate analysis, living further from the medical center was associated with shorter TTS (P = .01), whereas more recent year of surgery (P = .01), comorbid cardiovascular disease (P = .007), African-American (P = .005) or Hispanic race (P = .005), divorced relationship status (P = .01), and lower income (P = .003) were all associated with longer TTS. CONCLUSION Patients often experience widely variable intervals between the diagnosis and treatment of localized prostate cancer. Longer intervals before surgery may point to disparities in access to prostate cancer care, and not increased decision-making time by the patient. UROLOGY 80: 1027-1032, 2012. (C) 2012 Published by Elsevier Inc.
引用
收藏
页码:1027 / 1032
页数:6
相关论文
共 50 条
  • [21] The association between perineural invasion in mpMRI-targeted and/or systematic prostate biopsy and adverse pathological outcomes in robot-assisted radical prostatectomy
    Karsiyakali, N.
    Ozgen, M. Bulent
    Ozveren, B.
    Akbal, C.
    Dincer, A.
    Durak, H.
    Turkeri, L.
    ACTAS UROLOGICAS ESPANOLAS, 2022, 46 (06): : 377 - 384
  • [22] Clinical outcomes of salvage treatment in lymph node-positive prostate cancer patients after radical prostatectomy
    Kim, Dowook
    Kim, Dong-Yun
    Kim, Jae-Sung
    Hong, Sung Kyu
    Byun, Seok-Soo
    Lee, Sang Eun
    PLOS ONE, 2021, 16 (09):
  • [23] Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer After Radical Prostatectomy
    Moschini, Marco
    Sharma, Vidit
    Zattoni, Fabio
    Quevedo, J. Fernando
    Davis, Brian J.
    Kwona, Eugene
    Karnes, R. Jeffrey
    EUROPEAN UROLOGY, 2016, 69 (01) : 135 - 142
  • [24] Correlation between Upgrading of Prostate Biopsy and Biochemical Failure and Unfavorable Pathology after Radical Prostatectomy
    Ozden, Cuneyt
    Oztekin, Cetin Volkan
    Ugurlu, Ozgur
    Gokkaya, Serkan
    Yaris, Mehmet
    Memis, Ali
    UROLOGIA INTERNATIONALIS, 2009, 83 (02) : 146 - 150
  • [25] The Changes in Gleason Score Between the Diagnostic Biopsy and Radical Prostatectomy Pathology
    Hu, Jieping
    Hong, Yanyan
    Wang, Mengzhen
    Zeng, Jin
    Liu, Weipeng
    INDIAN JOURNAL OF SURGERY, 2024, 86 (02) : 361 - 367
  • [26] Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study
    Tarantino, Giovanni
    Crocetto, Felice
    Vito, Concetta Di
    Martino, Raffaele
    Pandolfo, Savio Domenico
    Creta, Massimiliano
    Aveta, Achille
    Buonerba, Carlo
    Imbimbo, Ciro
    FUTURE SCIENCE OA, 2020, 7 (03):
  • [27] Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy
    Hayden, Christopher
    Rahman, Syed
    Lokeshwar, Soum
    Choksi, Ankur
    Kim, Isaac Y. Y.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (07) : 729 - 734
  • [28] The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy
    Nyk, Lukasz
    Tayara, Omar
    Zabkowski, Tomasz
    Kryst, Piotr
    Andrychowicz, Aneta
    Malewski, Wojciech
    BMC UROLOGY, 2021, 21 (01)
  • [29] Interval from Prostate Biopsy to Radical Prostatectomy Does Not Affect Immediate Operative Outcomes for Open or Minimally Invasive Approach
    Park, Bumsoo
    Choo, Seol Ho
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Choi, Han Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (12) : 1688 - 1693
  • [30] The influence of body mass index on the cost of radical prostatectomy for prostate cancer
    Bolenz, Christian
    Gupta, Amit
    Hotze, Timothy
    Ho, Richard
    Cadeddu, Jeffrey A.
    Roehrborn, Claus G.
    Lotan, Yair
    BJU INTERNATIONAL, 2010, 106 (08) : 1188 - 1193